Abcam PLC Stock , ABCZF

	2023	2024	2025	2026
Revenue	-	5	5	6
Dividend	-	0.00	0.00	-
Dividend Yield (in %)	0.00 %	0.00 %	0.00 %	-
EPS	-	0.00	0.01	0.01
P/E Ratio	43.42	25.85	21.09	15.82
EBIT	-	1	2	2
EBITDA	-	2	2	3
Net Profit	-	1	1	2
Net Profit Adjusted	-	1	1	2
Pre-Tax Profit	-	1	2	2
Net Profit (Adjusted)	-	1	1	2
EPS (Non-GAAP) ex. SOE	-	-	-	-
EPS (GAAP)	-	0.00	0.00	0.01
Gross Income	-	4	4	5
Cash Flow from Investing	-	0	0	0
Cash Flow from Operations	-	1	2	2
Cash Flow from Financing	-	0	0	0
Cash Flow per Share	-	0.01	0.01	-
Free Cash Flow	-	1	1	1
Free Cash Flow per Share	-	0.00	-	-
Book Value per Share	-	0.04	0.06	-
Net Debt	-	-	-3	-4
Research & Development Exp.	-	0	0	0
Capital Expenditure	-	0	0	0
Selling, General & Admin. Exp.	-	2	3	-
Shareholder’s Equity	-	10	12	12
Total Assets	-	12	12	14

	Previous Quarter ending 12/31/22	Current Quarter	Next Quarter ending 06/30/23	Current Year ending 12/31/23	Next Year ending 12/31/24
Earnings Estimates
No. of Analysts	1	-	1	6	6
Average Estimate	0.169 GBP	-	0.185 GBP	0.363 GBP	0.429 GBP
Year Ago	-	-	-	-	0.363 GBP
Publish Date	3/20/2023	-	9/11/2023	-	-
Revenue Estimates
No. of Analysts	1	-	1	6	6
Average Estimate	213 GBP	-	219 GBP	439 GBP	475 GBP
Year Ago	-	-	-	-	439 GBP
Publish Date	3/20/2023	-	9/11/2023	-	-

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Abcam Dividend Calendar

Date	Name	Dividend	*yield	Currency
2021	Abcam PLC	-	-	GBP
2020	Abcam PLC	0.04	0.27	GBP
2019	Abcam PLC	0.12	0.82	GBP
2018	Abcam PLC	0.12	0.90	GBP
2017	Abcam PLC	0.10	1.05	GBP
2016	Abcam PLC	0.09	1.16	GBP
2015	Abcam PLC	0.08	1.58	GBP
2014	Abcam PLC	0.08	2.04	GBP
2013	Abcam PLC	0.07	1.55	GBP
2012	Abcam PLC	0.06	1.45	GBP
2011	Abcam PLC	0.05	1.26	GBP
2010	Abcam PLC	0.04	1.64	GBP
2009	Abcam PLC	0.02	1.77	GBP

*Yield of the Respective Date

Abcam PLC Calendar

Event	Estimate	Info	Date
Earnings Report	0.169 GBP	Q4 2022 Earnings Release	03/20/2023
Earnings Report	0.185 GBP	Q2 2023 Earnings Release	09/11/2023
Earnings Report	-	Q4 2023 Earnings Release	03/18/2024
Earnings Report	-	Q2 2024 Earnings Release	09/09/2024

Abcam Profile

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.

Moody’s Daily Credit Risk Score

Risk

Low
Medium
High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Abcam Shareholder

Owner	in %
T Rowe Price New Horizons Fund	3.57
Brown Capital Management - International Small Co. Fund (The)	2.63
T Rowe Price International Discovery Fund	1.87
Morgan Stanley Invt. Fds. - European Opportunity Fund	1.51
Fidelity Select Medical Technology & Devices Portfolio	1.31

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.